Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Allogene Therapeutics, Inc.ALLO · Entity 5243 | Director | June 18, 2026 | June 23, 2026 |
| PayPal Holdings, Inc.PYPL · Entity 2530 | Director | May 19, 2026 | May 20, 2026 |
| TPG Inc.TPG · Entity 3253 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Allogene Therapeutics, Inc.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 95,400 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 95,400 · Balance 95,400 F1: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.
PayPal Holdings, Inc.
Report date May 19, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,251 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 6,275 · Balance 20,251 F1: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.
TPG Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 20,988 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 4,181 · Balance 20,988 F1: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 21:24 UTC | TPG Inc. TPG · Entity 3253 | GrantClass A Common Stock | 4,181 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-26-000711 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,988 F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:34 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantRestricted Stock Unit · Derivative | 95,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-26-000021 · wk-form4_1782246849.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires not disclosed F1 · derivative.exercise_price: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. F1 · derivative.exercise_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. F1 · derivative.expiration_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Read SEC document |
| May 19, 2026 Filed May 20, 2026 23:02 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 6,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001754424-26-000002 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,251 F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 23:34 UTC | TPG Inc. TPG · Entity 3253 | SaleClass A Common Stock | 1,796 | $56.32 | $101,148.39 |
DisclosureSEC source: 0000947871-25-000674 · ownership.xml · nonDerivative · entry 2 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,807 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock were sold in multiple transactions at prices ranging from $56.14 to $56.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:34 UTC | TPG Inc. TPG · Entity 3253 | GrantClass A Common Stock | 2,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-25-000674 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,603 F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock ("Class A common stock") of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock ("Class A common stock") of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 01:03 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantRestricted Stock Unit · Derivative | 95,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000076 · wk-form4_1750727027.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires not disclosed F1 · derivative.exercise_price: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company. F1 · derivative.exercise_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company. F1 · derivative.expiration_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:18 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | SaleCommon Stock | 36,885 | $1.42 | $52,376.70 |
DisclosureSEC source: 0001737287-25-000066 · wk-form4_1749759007.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,431 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.38 to $1.445, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 06, 2025 Filed Jun 7, 2025 00:03 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | SaleCommon Stock | 3,795 | $73.00 | $277,036.14 |
DisclosureSEC source: 0001633917-25-000097 · edgardoc.xml · nonDerivative · entry 2 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,976 Read SEC document |
| June 05, 2025 Filed Jun 7, 2025 00:03 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-25-000097 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,771 F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:15 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | SaleCommon Stock | 13,313 | $2.43 | $32,350.59 |
DisclosureSEC source: 0001737287-25-000022 · wk-form4_1740086122.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,316 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.42 to $2.44, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 14, 2025 Filed Jan 15, 2025 22:36 UTC | TPG Inc. TPG · Entity 3253 | SaleClass A Common Stock | 1,695 | $61.91 | $104,930.67 |
DisclosureSEC source: 0000947871-25-000042 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,841 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of TPG Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $61.73 to $62.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:53 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | SaleCommon Stock | 9,136 | $2.18 | $19,916.48 |
DisclosureSEC source: 0001737287-24-000081 · wk-form4_1733867628.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,629 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.16 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 17, 2024 Filed Jul 17, 2024 21:37 UTC | TPG Inc. TPG · Entity 3253 | SaleClass A Common Stock | 4,089 | $46.55 | $190,331.91 |
DisclosureSEC source: 0000947871-24-000625 · ownership.xml · nonDerivative · entry 2 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,536 F2 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of the Issuer were sold in multiple transactions at prices ranging from $45.94 to $46.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:37 UTC | TPG Inc. TPG · Entity 3253 | GrantClass A Common Stock | 3,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-24-000625 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,625 F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:31 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | SaleCommon Stock | 18,641 | $2.28 | $42,488.43 |
DisclosureSEC source: 0001593968-24-000878 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,765 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:25 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantCommon Stock | 122,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000835 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,406 Read SEC document |
| May 24, 2024 Filed May 24, 2024 21:09 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | SaleCommon Stock | 4,422 | $61.65 | $272,616.30 |
DisclosureSEC source: 0001633917-24-000070 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,976 Read SEC document |
| May 22, 2024 Filed May 24, 2024 01:27 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 4,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-24-000064 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,398 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:14 UTC | TPG Inc. TPG · Entity 3253 | SaleClass A Common Stock | 6,390 | $43.97 | $280,980.44 |
DisclosureSEC source: 0000947871-24-000242 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,033 F1 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of TPG Inc. (the 'Issuer") were sold in multiple transactions at prices ranging from $43.47 to $44.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:26 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | SaleCommon Stock | 18,640 | $2.70 | $50,316.82 |
DisclosureSEC source: 0001593968-23-001520 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,456 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:12 UTC | TPG Inc. TPG · Entity 3253 | GrantClass A Common Stock | 5,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-23-000757 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,423 F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 21:06 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantCommon Stock | 74,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-23-001013 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,096 Read SEC document |
| May 24, 2023 Filed May 26, 2023 23:14 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 4,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-23-000095 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,976 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:08 UTC | TPG Inc. TPG · Entity 3253 | GrantRestricted Stock Units | 9,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-22-000790 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,312 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs represent an annual award that vests on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:57 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantStock Option (Right to Buy) · Derivative | 71,070 | $0.00 Strike: $9.62 | $0.00 |
DisclosureSEC source: 0001214659-22-008166 · marketforms-56488.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,070 Underlying: Common Stock · 71,070 shares Expires 2032-06-15 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 15, 2022. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 22:23 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 3,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-22-000118 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,526 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 01:20 UTC | TPG Inc. TPG · Entity 3253 | GrantRestricted Stock Units | 10,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000947871-22-000064 · ownership.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,170 F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). One-third of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continuous service through the vesting date. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 21:46 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantStock Option (Right to Buy) · Derivative | 28,015 | $0.00 Strike: $25.76 | $0.00 |
DisclosureSEC source: 0001214659-21-006502 · marketforms-53109.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,015 Underlying: Common Stock · 28,015 shares Expires 2031-06-10 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 10, 2021. Read SEC document |
| May 26, 2021 Filed May 27, 2021 20:50 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 1,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-21-000112 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,412 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:03 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantStock Option (Right to Buy) · Derivative | 16,640 | $0.00 Strike: $42.63 | $0.00 |
DisclosureSEC source: 0001214659-20-005493 · marketforms-49013.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,640 Underlying: Common Stock · 16,640 shares Expires 2030-06-05 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 5, 2020. Read SEC document |
| May 21, 2020 Filed May 22, 2020 22:33 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-20-000115 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| June 06, 2019 Filed Jun 25, 2019 00:05 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | GrantStock Option (Right to Buy) · Derivative | 26,025 | $0.00 Strike: $25.95 | $0.00 |
DisclosureSEC source: 0001209191-19-038868 · doc4.xml · derivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,025 Underlying: Common Stock · 26,025 shares Expires 2029-06-06 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 6, 2019. Read SEC document |
| May 22, 2019 Filed May 24, 2019 22:36 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 2,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-19-000150 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,503 F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 22:27 UTC | PayPal Holdings, Inc. PYPL · Entity 2530 | GrantCommon Stock | 1,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001633917-19-000021 · edgardoc.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,057 F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for Company common stock promptly following her appointment as a director of the Company. The number of shares of common stock granted represents the quotient of (A) $95,684.93 (representing the amount of the annual equity award (i.e., $275,000), prorated to reflect the number of days from the date of her appointment to the first anniversary of the most recent annual stockholders meeting), divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 21:33 UTC | Allogene Therapeutics, Inc. ALLO · Entity 5243 | OtherCommon Stock | 6,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055391 · doc4.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,535 F1 · kind: Automatic conversion of an outstanding convertible promissory note in the principal amount of $100,000 into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering at a conversion price of $15.30 per share. F1 · price: Automatic conversion of an outstanding convertible promissory note in the principal amount of $100,000 into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering at a conversion price of $15.30 per share. F2 · ownership.nature: Securities held in the name of the Messemer Family Trust dated February 18, 2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.